A Nosy New Lead

An antibiotic produced by a nose-dwelling bacterium shows potential against superbugs like MRSA, and offers hope the body could serve up more weapons to battle antibiotic resistance.

The discovery of the antibiotic, lugdunin, by Alexander Zipperer and Martin Konnerth of the University of Tübingen, is detailed in a study published in Nature.

It isn’t known if the chemical will lead to a successful drug. But, “Even if lugdunin itself doesn’t pan out, that doesn’t matter. The true value of Zipperer and Konnerth’s work lies not in just one chemical, but in highlighting an approach for finding more,” writes Ed Yong.

The Atlantic

Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top